ANTISENSE-OLIGONUKLEOTIDE

European patent · EP3532617 · In force

Register entry

Publication number
EP3532617
Application number
EP17865020
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 16, 2017
Published
Sep 4, 2019
Granted
Oct 25, 2023
Protection ends at the latest
Oct 15, 2037
Next annual fee due
Oct 31, 2026
IPC classes
C12N 15/113 (2010.01)
A61K 31/7088 (2006.01)
A61P 35/00 (2006.01)
Priority
SG 10201609048R 28.10.2016
PCT application
PCT/SG2017/050517 16.10.2017
PCT publication
WO2018/080393 03.05.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Sep 4, 2024

    Change

    Published in Swissreg on 04.09.2024

  4. Oct 30, 2023

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 30.10.2023

  5. Oct 25, 2023

    Granted

    Published in Swissreg on 25.10.2023

Parties

Holder

Agency for Science, Technology and Research

1 Fusionopolis Way 20-10 Connexis, Singapore 138632, SG

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

WEE, Keng Boon

Singapore 138632, SG

SURANA, Uttam

Singapore 138632, SG

LIN, Jing

Singapore 138632, SG

LIM, Bing

Singapore 138632, SG

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.